Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Heart Failure

  Free Subscription


Articles published in Cardiovasc Res

Retrieve available abstracts of 56 articles:
HTML format
Text format



Single Articles


    July 2018
  1. DOBREV D, Fender AC, Wehrens XHT
    Pro-arrhythmic RyR2 channels in heart failure: do their localisation and mechanism of activation really matter?
    Cardiovasc Res. 2018 Jul 3. pii: 5048462. doi: 10.1093.
    PubMed     Text format    


    June 2018
  2. IDRES S, Perrin G, Domergue V, Lefebvre F, et al
    Contribution of BKCa channels to vascular tone regulation by PDE3 and PDE4 is lost in heart failure.
    Cardiovasc Res. 2018 Jun 23. pii: 5043286. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. KARKKAINEN O, Tuomainen T, Mutikainen M, Lehtonen M, et al
    Heart specific PGC-1alpha deletion identifies metabolome of cardiac restricted metabolic heart failure.
    Cardiovasc Res. 2018 Jun 20. pii: 5040494. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. NATTEL S
    Catheter ablation of atrial fibrillation and outcomes in heart failure patients: seeking the treasure in the CASTLE.
    Cardiovasc Res. 2018;114:e50-e52.
    PubMed     Text format    


    April 2018
  5. VAN DER ENDE MY, Said MA, van Veldhuisen DJ, Verweij N, et al
    Genome Wide Studies of Heart Failure and Endophenotypes: lessons learned and future directions.
    Cardiovasc Res. 2018 Apr 18. pii: 4975446. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. DRIES E, Santiago DJ, Gilbert G, Lenaerts I, et al
    Hyperactive ryanodine receptors in human heart failure and ischemic cardiomyopathy reside outside of couplons.
    Cardiovasc Res. 2018 Apr 14. pii: 4970798. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. BORGOGNONE A, Shantsila E, Worrall SM, Prompunt E, et al
    Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation.
    Cardiovasc Res. 2018 Apr 12. pii: 4969512. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  8. DE ROSA M, Gambardella J, Shu J, Santulli G, et al
    Dietary Fat is a Key Determinant in Balancing Mitochondrial Dynamics in Heart Failure: A Novel Mechanism Underlying the Obesity Paradox.
    Cardiovasc Res. 2018 Mar 22. pii: 4951453. doi: 10.1093.
    PubMed     Text format    


    November 2017
  9. FLORIJN BW, Bijkerk R, van der Veer E, van Zonneveld AJ, et al
    Gender and cardiovascular disease: Are sex-biased miRNA networks a driving force behind heart failure with preserved ejection fraction in women?
    Cardiovasc Res. 2017 Nov 24. pii: 4657087. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2017
  10. RIPPLINGER CM
    From drugs to devices and back again: chemical vagal nerve stimulation for the treatment of heart failure.
    Cardiovasc Res. 2017;113:1270-1272.
    PubMed     Text format    


    July 2017
  11. FRASER AG, Gillebert TC, Leite-Moreira AF
    Ventricular-arterial coupling in heart failure with preserved ejection fraction: the devil is in the details.
    Cardiovasc Res. 2017;113:844-846.
    PubMed     Text format    


    June 2017
  12. SCHOBESBERGER S, Wright P, Tokar S, Bhargava A, et al
    T-tubule remodelling disturbs localized beta2-adrenergic signalling in rat ventricular myocytes during the progression of heart failure.
    Cardiovasc Res. 2017;113:770-782.
    PubMed     Text format     Abstract available


    May 2017
  13. ABDURRACHIM D, Nabben M, Hoerr V, Kuhlmann MT, et al
    Diabetic db/db mice do not develop heart failure upon pressure overload: A longitudinal in vivo PET, MRI, and MRS study on cardiac metabolic, structural, and functional adaptations.
    Cardiovasc Res. 2017 May 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. VILLALBA-ORERO M, Lopez-Olaneta MM, Gonzalez-Lopez E, Padron-Barthe L, et al
    Lung ultrasound as a translational approach for non-invasive assessment of heart failure with reduced or preserved ejection fraction in mice.
    Cardiovasc Res. 2017 May 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. GARROTT K, Dyavanapalli J, Cauley E, Kate Dwyer M, et al
    Chronic activation of hypothalamic oxytocin neurons improves cardiac function during left ventricular hypertrophy-induced heart failure.
    Cardiovasc Res. 2017 May 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. LI J, Yousefi K, Ding W, Singh J, et al
    Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure.
    Cardiovasc Res. 2017;113:633-643.
    PubMed     Text format     Abstract available


  17. NONHOFF J, Ricke-Hoch M, Mueller M, Stapel B, et al
    Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.
    Cardiovasc Res. 2017;113:598-608.
    PubMed     Text format     Abstract available


  18. HAUSENLOY DJ, Garcia-Dorado D, Botker HE, Davidson SM, et al
    Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.
    Cardiovasc Res. 2017;113:564-585.
    PubMed     Text format     Abstract available


    April 2017
  19. CROSSMAN DJ, Shen X, Jullig M, Munro M, et al
    Increased collagen within the transverse tubules in human heart failure.
    Cardiovasc Res. 2017 Apr 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. PEREZ DEL VILLAR C, Savvatis K, Lopez B, Kasner M, et al
    Impact of acute hypertension transients on diastolic function in patients with heart failure with preserved ejection fraction.
    Cardiovasc Res. 2017 Apr 11. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  21. SATO T, Sato C, Kadowaki A, Watanabe H, et al
    ELABELA - APJ axis protects from pressure overload heart failure and Angiotensin II-induced cardiac damage.
    Cardiovasc Res. 2017 Mar 23. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2017
  22. LI J, Yousefi K, Ding W, Singh J, et al
    Osteopontin RNA Aptamer Can Prevent and Reverse Pressure Overload-Induced Heart Failure.
    Cardiovasc Res. 2017 Feb 1. doi: 10.1093.
    PubMed     Text format    


  23. GRECO S, Zaccagnini G, Fuschi P, Voellenkle C, et al
    Increased Bace1-As Long Noncoding Rna And beta-Amyloid Levels In Heart Failure.
    Cardiovasc Res. 2017 Feb 1. doi: 10.1093.
    PubMed     Text format    


  24. ELIA L, Quintavalle M, Condorelli G
    Circular RNAs and heart failure: new players for an old disease.
    Cardiovasc Res. 2017 Feb 1. doi: 10.1093.
    PubMed     Text format    


    January 2017
  25. NONHOFF J, Ricke-Hoch M, Mueller M, Stapel B, et al
    Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.
    Cardiovasc Res. 2017 Jan 20. pii: cvw245. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2016
  26. LI L, Li J, Drum BM, Chen Y, et al
    Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


    July 2016
  27. TAKADA S, Masaki Y, Kinugawa S, Matsumoto J, et al
    Dipeptidyl peptidase-4 inhibitor improved exercise capacity and mitochondrial biogenesis in mice with heart failure via activation of GLP-1 receptor signaling.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  28. LIU L, An X, Li Z, Song Y, et al
    The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
    Cardiovasc Res. 2016;111:56-65.
    PubMed     Text format     Abstract available


  29. SCHEID LM, Mosqueira M, Hein S, Kossack M, et al
    Essential light chain S195 phosphorylation is required for cardiac adaptation under physical stress.
    Cardiovasc Res. 2016;111:44-55.
    PubMed     Text format     Abstract available


    June 2016
  30. BOOIJ HG, Yu H, de Boer RA, van de Kolk CW, et al
    Overexpression of A kinase interacting protein 1 attenuates myocardial ischemia / reperfusion injury, but does not influence heart failure development.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  31. HILLE S, Dierck F, Kuhl C, Sosna J, et al
    Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling.
    Cardiovasc Res. 2016;110:381-94.
    PubMed     Text format     Abstract available


    May 2016
  32. GOGIRAJU R, Schroeter MR, Bochenek ML, Hubert A, et al
    Endothelial Deletion of Protein Tyrosine Phosphatase-1B Protects Against Pressure Overload-Induced Heart Failure in Mice.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  33. KOOIJ V, Viswanathan MC, Lee DI, Rainer PP, et al
    Profilin modulates sarcomeric organization and mediates cardiomyocyte hypertrophy.
    Cardiovasc Res. 2016;110:238-48.
    PubMed     Text format     Abstract available


    March 2016
  34. MASSENGILL MT, Ashraf HM, Chowdhury RR, Chrzanowski SM, et al
    Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  35. BYRNE NJ, Levasseur J, Sung MM, Masson G, et al
    Normalization of Cardiac Substrate Utilization and Left Ventricular Hypertrophy Precede Functional Recovery in Heart Failure Regression.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


    January 2016
  36. GOH KY, Qu J, Hong H, Liu T, et al
    Impaired mitochondrial network excitability in failing guinea-pig cardiomyocytes.
    Cardiovasc Res. 2016;109:79-89.
    PubMed     Text format     Abstract available


    December 2015
  37. KUMAGAI S, Nakayama H, Fujimoto M, Honda H, et al
    Myeloid cell-derived LRG attenuates adverse cardiac remodelling after myocardial infarction.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


    November 2015
  38. MAACK C
    Orphaned mitochondria in heart failure.
    Cardiovasc Res. 2015.
    PubMed     Text format    


    September 2015
  39. LUCAS A, Mialet-Perez J, Daviaud D, Parini A, et al
    Gadd45gamma regulates cardiomyocytes death and post-myocardial infarction left ventricular remodelling.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


    June 2015
  40. FERT-BOBER J, Giles JT, Holewinski RJ, Kirk JA, et al
    Citrullination of myofilament proteins in heart failure.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


  41. HAUBNER BJ, Moik D, Schuetz T, Reiner MF, et al
    In vivo cardiac role of migfilin during experimental pressure overload.
    Cardiovasc Res. 2015;106:398-407.
    PubMed     Text format     Abstract available


    May 2015
  42. YABLUCHANSKIY A, Ma Y, Lindsey ML
    Syndecan-4: a novel regulator of collagen synthesis and deposition in the pressure-overloaded myocardium.
    Cardiovasc Res. 2015;106:178-9.
    PubMed     Text format    


  43. SEYMOUR AM, Giles L, Ball V, Miller JJ, et al
    In vivo assessment of cardiac metabolism and function in the abdominal aortic banding model of compensated cardiac hypertrophy.
    Cardiovasc Res. 2015;106:249-60.
    PubMed     Text format     Abstract available


  44. HERUM KM, Lunde IG, Skrbic B, Louch WE, et al
    Syndecan-4 is a key determinant of collagen cross-linking and passive myocardial stiffness in the pressure-overloaded heart.
    Cardiovasc Res. 2015;106:217-26.
    PubMed     Text format     Abstract available


    April 2015
  45. DI LISA F, Itoh N
    Cardiac Fgf21 synthesis and release: an autocrine loop for boosting up antioxidant defenses in failing hearts.
    Cardiovasc Res. 2015;106:1-3.
    PubMed     Text format    


  46. SKRBIC B, Engebretsen KV, Strand ME, Lunde IG, et al
    Lack of collagen VIII reduces fibrosis and promotes early mortality and cardiac dilatation in pressure overload in mice.
    Cardiovasc Res. 2015;106:32-42.
    PubMed     Text format     Abstract available


  47. PLANAVILA A, Redondo-Angulo I, Ribas F, Garrabou G, et al
    Fibroblast growth factor 21 protects the heart from oxidative stress.
    Cardiovasc Res. 2015;106:19-31.
    PubMed     Text format     Abstract available


    March 2015
  48. XU X, Tan X, Tampe B, Nyamsuren G, et al
    Epigenetic balance of aberrant Rasal1 promoter methylation and hydroxymethylation regulates cardiac fibrosis.
    Cardiovasc Res. 2015;105:279-91.
    PubMed     Text format     Abstract available


    January 2015
  49. BOSSUYT J
    Nuclear remodelling: a consequence of nucleocytoplasmic traffic run amok?
    Cardiovasc Res. 2015;105:6-7.
    PubMed     Text format    


  50. SEIDEL M, Thomas NL, Williams AJ, Lai FA, et al
    Dantrolene rescues aberrant N-terminus intersubunit interactions in mutant pro-arrhythmic cardiac ryanodine receptors.
    Cardiovasc Res. 2015;105:118-28.
    PubMed     Text format     Abstract available


  51. CHAHINE MN, Mioulane M, Sikkel MB, O'Gara P, et al
    Nuclear pore rearrangements and nuclear trafficking in cardiomyocytes from rat and human failing hearts.
    Cardiovasc Res. 2015;105:31-43.
    PubMed     Text format     Abstract available


    October 2014
  52. BANDARU S, Gronros J, Redfors B, Cil C, et al
    Deficiency of filamin A in endothelial cells impairs left ventricular remodeling after myocardial infarction.
    Cardiovasc Res. 2014.
    PubMed     Text format     Abstract available


    July 2014
  53. WESTERMANN D, Heymans S
    Fibrosis or hypertrophy: let TIMPs decide.
    Cardiovasc Res. 2014;103:196-7.
    PubMed     Text format    


  54. FAN D, Takawale A, Basu R, Patel V, et al
    Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
    Cardiovasc Res. 2014;103:268-80.
    PubMed     Text format     Abstract available


  55. ZHU W, Zhang W, Shou W, Field LJ, et al
    P53 inhibition exacerbates late-stage anthracycline cardiotoxicity.
    Cardiovasc Res. 2014;103:81-9.
    PubMed     Text format     Abstract available


  56. MATHIYALAGAN P, Keating ST, Du XJ, El-Osta A, et al
    Chromatin modifications remodel cardiac gene expression.
    Cardiovasc Res. 2014;103:7-16.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: